Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $13
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Hold rating on Pediatrix Medical Group (NYSE:MD) while raising the price target from $10 to $13.
October 07, 2024 | 12:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has maintained a Hold rating on Pediatrix Medical Group and increased the price target from $10 to $13, indicating a more positive outlook.
The increase in price target from $10 to $13 by Truist Securities suggests a more optimistic view on Pediatrix Medical Group's future performance, which could positively influence investor sentiment and potentially lead to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100